HEMODYNAMICS ASSOCIATED WITH PRE-PROCEDURAL ELEVATED B-TYPE NATRIURETIC PEPTIDE IN PATIENTS UNDERGOING TRANSCATHETER AORTIC VALVE REPLACEMENT